Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1810031000168119 | daclizumab (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1810041000168111 | daclizumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| daclizumab | Is a | medicinal product | true | Inferred relationship | Some | ||
| daclizumab | has intended active ingredient | daclizumab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| daclizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) | Is a | True | daclizumab | Inferred relationship | Some | |
| daclizumab 150 mg/mL injection, pen device | Is a | True | daclizumab | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR